Cubist Systematic Strategies’s MaxCyte MXCT Stock Holding History

Cubist Systematic Strategies’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$5.09K	Buy	+3,225	New	+$5.61K	﹤0.01%	2938
2023 Q2	–	Sell	-12,750	Closed	-$63.1K	–	4025
2023 Q1	$63.1K	Buy	12,750 +12,514	+5,303%	+$61.6K	﹤0.01%	3526
2022 Q4	$1.29K	Sell	236 -13,022	-98%	-$79.9K	﹤0.01%	4145
2022 Q3	$86K	Buy	13,258 +2,001	+18%	+$11.2K	﹤0.01%	4050
2022 Q2	$53K	Sell	11,257 -15,593	-58%	-$76.8K	﹤0.01%	4087
2022 Q1	$188K	Buy	+26,850	New	+$183K	﹤0.01%	3073
2021 Q4	–	Sell	-31,600	Closed	-$386K	–	3562
2021 Q3	$386K	Buy	+31,600	New	+$477K	﹤0.01%	2201

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

AIM

AXA Investment Managers Puteaux, France $37.1B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's MXCT Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in MaxCyte (MXCT) in Q3 2025: 3,225 shares worth $5.09K. The stake represents ﹤0.01% of the portfolio and ranks #2938 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in MXCT as recently as Q1 2023.

Cubist Systematic Strategies first reported a position in MXCT in Q3 2021 and has held it in 7 quarters since. The position peaked at $386K in Q3 2021. 112 funds tracked by Wall St. Rank hold MXCT as of Q3 2025.

Cubist Systematic Strategies held 3,225 shares of MaxCyte worth $5.09K as of Q3 2025.
MaxCyte was a new Cubist Systematic Strategies position in Q3 2025.
MaxCyte made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2938 holding.
Cubist Systematic Strategies first reported a position in MaxCyte in Q3 2021 and has held it in 7 quarters since.
Cubist Systematic Strategies's MaxCyte position peaked at $386K in Q3 2021.
112 funds tracked by Wall St. Rank held MaxCyte as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.